Health Apps (DiGAs) and Care Apps (DiPAs) on prescription bring enormous opportunities for patients and our entire healthcare system.
With DiGAs and DiPAs established medical device manufacturers and pharmaceutical companies can get closer to patients and providers, implement digital, data-driven business models, create a strong competitive advantage and create new revenue streams.
Zühlke is your strategic partner for the development of DiGAs and DiPAs - from the initial idea to approval and operation. Either by co-development with startups or by creating your own digital solutions from scratch - with us you minimize your risks and optimize time-to-market. Like this, you can expand your existing portfolio quickly and securely by digital, patient-centric solutions and establish holistic therapy solutions.
DiGAs and DiPAs are considered as one of the biggest breakthroughs in the digitalization of the German healthcare system. But for a lot of companies, some quite important questions remain unanswered:
How can you benefit from this trend as an established Medtech or Pharma company?
What is the best approach when developing new digital offerings?
What (regulatory) obligations and risks need to be considered?
What are the most promising business cases?
How can you ensure a successful collaboration with innovative ‘Tech’ partners?
To answer questions like these, it is helpful to have an experienced partner who approaches digital health innovation holistically.
With Zühlke at your side, you can:
Complement your existing product portfolio quickly and with minimal risk by digital solutions (DiGAs, DiPAs), which are internationally compliant (incl. approval according to MDR and FDA).
Make a strategic decision to realize your own ideas, to enter partnerships or to buy solutions or providers.
Extend software solutions and digital health platforms with self-developed devices - all from a single trusted partner (e.g. drug delivery systems, diagnostic devices, wearables, ...)
We enable you to become successful with digital health solutions quickly and with minimal risk.
Dr. Stefan Weiss is Principle Business Innovation Consultant at the Zühlke Group and has a broad background in Neuroscience combined with a profound expertise in economics and innovation management. Before joining Zühlke, Stefan shaped the future of Healthcare and Life Sciences at the Innovation Center of Merck KGaA. He is passionate about the digitalization of the Pharma- and MedTech Industry with innovative solutions and business models by applying his scientific and economic expertise. At Zühlke, he extends technical excellence with domain-specific insights and thereby strengthens the partnerships with Pharma- and MedTech customers
Nicolas supports the Healthcare market unit at Zühlke Asia, focusing on innovative digital strategy and product development initiatives with global and local customers. Nicolas is passionate about helping clients connect the dots, bridging the gap from conceptualisation to implementation.
With his years of experience and a strong innovative mindset, Helmut Taumberger is digital transformation personified. As a Managing Director Cross Markets in Austria, he is responsible for steering the company’s strategic orientation and development. A qualified engineer, he has worked in the IT sector since 2003 and has lent his substantial expertise to various international businesses. He likes nothing more than coming up with practical strategies and getting people excited about technological change.
Myles Davidson is an experienced leader for the digital transformation of companies and product innovation. Significant experience in driving business initiatives on a local and international level in a complex and rapidly changing environment. Myles is known as trusted advisor for clients at C- and board-level for strategic questions around business innovation and technology.
